Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1741-1745

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zysow, B. R.
Right arrow Articles by Rubanyi, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zysow, B. R.
Right arrow Articles by Rubanyi, G. M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:1741-1745.)
© 1997 American Heart Association, Inc.


Articles

Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice

Bernice R. Zysow; Katalin Kauser; Richard M. Lawn; ; Gabor M. Rubanyi

From the Falk Cardiovascular Research Center, Stanford University School of Medicine, Palo Alto, Calif (B.R.Z., R.M.L.) and Cardiovascular Department, Berlex Biosciences, Richmond, Calif (K.K., G.M.R.).

Correspondence to Gabor M. Rubanyi, MD, PhD, Cardiovascular Department, Berlex Biosciences, 15049 San Pablo Ave., Richmond, CA 94804-0099.

Abstract Plasma levels of lipoprotein(a) (Lp(a)), are regulated by the synthetic rate of apolipoprotein(a) (apo(a)), a major protein component of this atherogenic lipoprotein. Exogenously administered sex steroid hormones are potent regulators of plasma Lp(a) concentrations. We utilized a recently developed apo(a) yeast artificial chromosome (YAC) transgenic mouse model to study the effects of ovariectomy, estrus cycle, and exogenous administration of ethinyl-estradiol, the partial estrogen receptor agonist, tamoxifen, and progesterone on circulating apo(a) plasma levels. Analysis of liver RNA revealed that estrogen and tamoxifen exerts their plasma apo(a) lowering effect at the level of apo(a) mRNA. This action of estrogen and tamoxifen may contribute to their antiatherosclerotic and cardiovascular protective effect.


Key Words: apolipoprotein(a) • gene regulation • estrogen • lipoprotein(a) • atherosclerosis




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Huby, V. Afzal, C. Doucet, R. M. Lawn, E. L. Gong, M. J. Chapman, J. Thillet, and E. M. Rubin
Regulation of the Expression of the Apolipoprotein(a) Gene: Evidence for a Regulatory Role of the 5' Distal Apolipoprotein(a) Transcription Control Region Enhancer in Yeast Artificial Chromosome Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., September 1, 2003; 23(9): 1633 - 1639.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Kennedy, K. Byth, C. L. Clarke, and A. deFazio
Cell Proliferation in the Normal Mouse Mammary Gland and Inhibition by Phenylbutyrate
Mol. Cancer Ther., October 1, 2002; 1(12): 1025 - 1033.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Wang, J. Boedeker, H. H. Hobbs, and A. L. White
Determinants of human apolipoprotein [a] secretion from mouse hepatocyte cultures
J. Lipid Res., January 1, 2001; 42(1): 60 - 69.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Tao, F. Acquati, S. M. Marcovina, and H. H. Hobbs
Human Growth Hormone Increases Apo(a) Expression in Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2439 - 2447.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
F. Acquati, R. Hammer, B. Ercoli, V. Mooser, R. Tao, V. Rönicke, A. Michalich, G. Chiesa, R. Taramelli, H. H. Hobbs, et al.
Transgenic mice expressing a human apolipoprotein[a] allele
J. Lipid Res., June 1, 1999; 40(6): 994 - 1006.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. Boffelli, D. A. Zajchowski, Z. Yang, and R. M. Lawn
Estrogen Modulation of Apolipoprotein(a) Expression. IDENTIFICATION OF A REGULATORY ELEMENT
J. Biol. Chem., May 28, 1999; 274(22): 15569 - 15574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
K. Nilausen and H. Meinertz
Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein
Am. J. Clinical Nutrition, March 1, 1999; 69(3): 419 - 425.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Nassir, D. K. Bonen, and N. O. Davidson
Apolipoprotein(a) Synthesis and Secretion from Hepatoma Cells Is Coupled to Triglyceride Synthesis and Secretion
J. Biol. Chem., July 10, 1998; 273(28): 17793 - 17800.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Ramharack, D. Barkalow, and M. A. Spahr
Dominant Negative Effect of TGF-ß1 and TNF-{alpha} on Basal and IL-6–Induced Lipoprotein(a) and Apolipoprotein(a) mRNA Expression in Primary Monkey Hepatocyte Cultures
Arterioscler. Thromb. Vasc. Biol., June 1, 1998; 18(6): 984 - 990.
[Abstract] [Full Text] [PDF]